Fortress Biotechprfa 25 Stock Gross Profit
| CNB0 Stock | EUR 5.85 0.15 2.50% |
Fundamental analysis of FORTRESS BIOTECHPRFA allows traders to better anticipate movements in FORTRESS BIOTECHPRFA's stock price by examining its financial health and performance throughout various phases of its business cycle.
FORTRESS |
FORTRESS BIOTECHPRFA 25 Company Gross Profit Analysis
FORTRESS BIOTECHPRFA's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current FORTRESS BIOTECHPRFA Gross Profit | (85.66 M) |
Most of FORTRESS BIOTECHPRFA's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, FORTRESS BIOTECHPRFA 25 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, FORTRESS BIOTECHPRFA 25 reported (85.66 Million) of gross profit. This is 103.82% lower than that of the Healthcare sector and 109.01% lower than that of the Biotechnology industry. The gross profit for all Germany stocks is 100.31% higher than that of the company.
FORTRESS Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses FORTRESS BIOTECHPRFA's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of FORTRESS BIOTECHPRFA could also be used in its relative valuation, which is a method of valuing FORTRESS BIOTECHPRFA by comparing valuation metrics of similar companies.FORTRESS BIOTECHPRFA is currently under evaluation in gross profit category among its peers.
FORTRESS Fundamentals
| Return On Equity | -1.43 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (1.17) % | |||
| Operating Margin | (2.63) % | |||
| Shares Owned By Institutions | 1.80 % | |||
| Revenue | 77.61 M | |||
| Gross Profit | (85.66 M) | |||
| EBITDA | (197.84 M) | |||
| Net Income | (42.98 M) | |||
| Cash And Equivalents | 289.9 M | |||
| Cash Per Share | 2.98 X | |||
| Total Debt | 98.04 M | |||
| Debt To Equity | 0.40 % | |||
| Current Ratio | 5.91 X | |||
| Book Value Per Share | 0.57 X | |||
| Cash Flow From Operations | (83.48 M) | |||
| Earnings Per Share | (0.82) X | |||
| Number Of Employees | 173 | |||
| Beta | 1.9 | |||
| Annual Yield | 0.12 % |
About FORTRESS BIOTECHPRFA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze FORTRESS BIOTECHPRFA 25's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of FORTRESS BIOTECHPRFA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of FORTRESS BIOTECHPRFA 25 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Other Information on Investing in FORTRESS Stock
FORTRESS BIOTECHPRFA financial ratios help investors to determine whether FORTRESS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in FORTRESS with respect to the benefits of owning FORTRESS BIOTECHPRFA security.